Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
383.00    2.00 (0.52%)
Bid:
378.00
Ask:
384.50
Spread: 6.50 (1.72%)
Market Cap: £1.96b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Directorate Change

29 Jul 2025 16:32

RNS Number : 0414T
Caledonia Investments PLC
29 July 2025
 

 

Caledonia Investments plc

 

Directorate change

 

Caledonia Investments plc ("Caledonia" or the "Company") announces that Lynn Fordham, who has served as a non-executive director of the Company since 1 January 2022, has given notice of her resignation with effect from 31 August 2025.

 

Farah Buckley, who has served on the Board since March 2023, has been appointed as an additional member of the Company's Audit and Risk Committee from 1 August 2025 and will succeed Lynn as its chair on 1 September 2025. The Board will now begin the search for an additional non-executive director.

 

David Stewart, Caledonia's Chair, commented:

 

"On behalf of the Board, I would like to thank Lynn for the considerable contribution that she has made to Caledonia and wish her well for the future.

 

"I am delighted that Farah will join the Audit and Risk Committee and will succeed Lynn as its chair."

 

Enquiries

 

Company contacts

Caledonia Investments plc

+44 20 7802 8080

investorrelations@caledonia.com

 

David Stewart

Chairman

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

 

caledonia@teneo.com

29 July 2025

 

Notes:

 

In accordance with section 430 (2B) of the Companies Act 2006, Caledonia confirms that, other than fees payable to Lynn Fordham as a non-executive director up to the effective date of her resignation, no remuneration or payment has been or will be made in connection with her cessation as a director of the Company.

 

Caledonia Investments plc

 

Caledonia is a FTSE 250 self-managed investment trust company with a long track record of delivering consistent returns and progressive annual dividend payments to shareholders.

 

Our aim is to generate long-term compounding real returns that outperform inflation by 3%-6% over the medium to long term, and the FTSE All-Share index over 10 years.

 

We are a long-term investor and hold investments in both listed and private markets across three pools: Public Companies, Private Capital and Funds. Each has a strategic allocation of capital, investment strategy and target return. The result is a well-balanced diversified portfolio of investments with a global reach.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUUWMUPAGAB
Date   Source Headline
27th Aug 20215:10 pmRNSTransaction in Own Shares
20th Aug 20214:56 pmRNSTransaction in Own Shares
20th Aug 202110:41 amRNSHolding(s) in Company
13th Aug 20215:13 pmRNSTransaction in Own Shares
9th Aug 202112:12 pmRNSHolding(s) in Company
6th Aug 20215:10 pmRNSTransaction in Own Shares
5th Aug 20219:19 amRNSNet Asset Value(s)
2nd Aug 20217:00 amRNSTotal Voting Rights
23rd Jul 20215:23 pmRNSTransaction in Own Shares
21st Jul 20215:18 pmRNSGovernance Committee Membership
21st Jul 20215:14 pmRNSResult of AGM
16th Jul 20215:08 pmRNSTransaction in Own Shares
16th Jul 20214:29 pmRNSChange of Auditor
7th Jul 202111:50 amRNSNet Asset Value(s) and Portfolio Update
30th Jun 20215:51 pmRNSTotal Voting Rights
30th Jun 20215:50 pmRNSTransaction in Own Shares
28th Jun 20217:00 amRNSTransaction in Own Shares
17th Jun 20215:09 pmRNSAnnual Financial Report
10th Jun 20219:01 amRNSHolding(s) in Company
7th Jun 20214:46 pmRNSDirector/PDMR Shareholding
7th Jun 20214:37 pmRNSDirector/PDMR Shareholding
4th Jun 202111:58 amRNSNet Asset Value(s)
1st Jun 20217:00 amRNSCaledonia Private Capital sells DSE
27th May 20217:00 amRNSFinal Results
7th May 202111:39 amRNSNet Asset Value(s)
6th May 20218:13 amRNSHolding(s) in Company
9th Apr 20219:01 amRNSUnaudited net asset value and portfolio update
25th Mar 20215:45 pmRNSHolding(s) in Company
17th Mar 202110:03 amRNSDisposal
5th Mar 202112:27 pmRNSNet Asset Value(s)
16th Feb 20219:01 amRNSDirector Declaration
4th Feb 20219:11 amRNSNet Asset Value(s)
8th Jan 202110:39 amRNSNet Asset Value and Portfolio Update
7th Dec 202010:50 amRNSNet Asset Value(s)
27th Nov 20207:00 amRNSResult of Audit Tender
24th Nov 20207:00 amRNSHalf-year Report
6th Nov 202010:17 amRNSNet Asset Value(s)
7th Oct 202012:00 pmRNSNet Asset Value(s)
23rd Sep 20203:37 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:13 amRNSHolding(s) in Company
21st Sep 20203:02 pmRNSDirector/PDMR Shareholding
4th Sep 20202:40 pmRNSNet Asset Value(s)
6th Aug 20204:08 pmRNSNet Asset Value(s)
5th Aug 20204:15 pmRNSDirector/PDMR Shareholding
5th Aug 20201:57 pmRNSDirector/PDMR Shareholding
29th Jul 20204:36 pmRNSResult of AGM
15th Jul 202010:52 amRNSPortfolio Update
7th Jul 202010:41 amRNSNet Asset Value(s)
1st Jul 202012:32 pmRNSBlock listing Interim Review
24th Jun 20204:37 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.